Home Journals The Efficacy of Lactobacillus-Containing Probiotic Supplementation in Hemodialysis Patients: A Randomized, Double-Blind, Placebo-Controlled Trial

The Efficacy of Lactobacillus-Containing Probiotic Supplementation in Hemodialysis Patients: A Randomized, Double-Blind, Placebo-Controlled Trial

Credits to the Source Link Obum
The Efficacy of Lactobacillus-Containing Probiotic Supplementation in Hemodialysis Patients: A Randomized, Double-Blind, Placebo-Controlled Trial
    • Foley R.N.
    • Parfrey P.S.
    • Sarnak M.J.

    Clinical epidemiology of cardiovascular disease in chronic renal disease.

    Am J Kidney Dis. 1998; 32: S112-S119

    • Tonelli M.
    • Wiebe N.
    • Culleton B.
    • et al.

    Chronic kidney disease and mortality risk: a systematic review.

    J Am Soc Nephrol. 2006; 17: 2034-2047

  • The clinical epidemiology of cardiac disease in chronic renal failure.

    J Am Soc Nephrol. 1999; 10: 1606-1615

    • McClellan W.M.
    • Chertow G.M.

    Beyond Framingham: cardiovascular risk profiling in ESRD.

    J Am Soc Nephrol. 2005; 16: 1539-1541

    • Schiffrin E.L.
    • Lipman M.L.
    • Mann J.F.

    Chronic kidney disease: effects on the cardiovascular system.

    Circulation. 2007; 116: 85-97

    • Ilori T.O.
    • Wang X.
    • Huang M.
    • et al.

    Oxidative balance score and the risk of end-stage renal disease and cardiovascular disease.

    Am J Nephrol. 2017; 45: 338-345

    • Lim P.S.
    • Chen H.P.
    • Chen C.H.
    • et al.

    Association between redox status of serum albumin and peritoneal membrane transport properties in patients on peritoneal dialysis.

    Blood Purif. 2015; 40: 243-249

    • Stenvinkel P.
    • Carrero J.J.
    • Axelsson J.
    • et al.

    Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?.

    Clin J Am Soc Nephrol. 2008; 3: 505-521

    • Beberashvili I.
    • Sinuani I.
    • Azar A.
    • et al.

    IL-6 levels, nutritional status, and mortality in prevalent hemodialysis patients.

    Clin J Am Soc Nephrol. 2011; 6: 2253-2263

    • Ikizler T.A.
    • Wingard R.L.
    • Harvell J.
    • et al.

    Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: a prospective study.

    Kidney Int. 1999; 55: 1945-1951

    • Libetta C.
    • Sepe V.
    • Esposito P.
    • et al.

    Oxidative stress and inflammation: implications in uremia and hemodialysis.

    Clin Biochem. 2011; 44: 1189-1198

    • Ori Y.
    • Bergman M.
    • Bessler H.
    • et al.

    Cytokine secretion and markers of inflammation in relation to acidosis among chronic hemodialysis patients.

    Blood Purif. 2013; 35: 181-186

    • Shi K.
    • Wang F.
    • Jiang H.
    • et al.

    Gut bacterial translocation may aggravate microinflammation in hemodialysis patients.

    Dig Dis Sci. 2014; 59: 2109-2117

    • Lau W.L.
    • Savoj J.
    • Nakata M.B.
    • et al.

    Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins.

    Clin Sci (Lond). 2018; 132: 509-522

    • Montemurno E.
    • Cosola C.
    • Dalfino G.
    • et al.

    What would you like to eat, Mr CKD microbiota? A mediterranean diet, please! Kidney.

    Blood Press Res. 2014; 39: 114-123

    • Rossi M.
    • Johnson D.W.
    • Campbell K.L.

    The kidney-gut Axis: implications for nutrition care.

    J Ren Nutr. 2015; 25: 399-403

    • Vaziri N.D.
    • Wong J.
    • Pahl M.
    • et al.

    Chronic kidney disease alters intestinal microbial flora.

    Kidney Int. 2013; 83: 308-315

    • Wong J.
    • Piceno Y.M.
    • DeSantis T.Z.
    • et al.

    Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD.

    Am J Nephrol. 2014; 39: 230-237

  • The gastrointestinal tract in uremia.

    Dig Dis Sci. 1993; 38: 257-268

    • Vaziri N.D.
    • Freel R.W.
    • Hatch M.

    Effect of chronic experimental renal insufficiency on urate metabolism.

    J Am Soc Nephrol. 1995; 6: 1313-1317

    • Vaziri N.D.
    • Yuan J.
    • Rahimi A.
    • et al.

    Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation.

    Nephrol Dial Transpl. 2012; 27: 2686-2693

    • Vaziri N.D.
    • Yuan J.
    • Nazertehrani S.
    • et al.

    Chronic kidney disease causes disruption of gastric and small intestinal epithelial tight junction.

    Am J Nephrol. 2013; 38: 99-103

    • Wu M.J.
    • Chang C.S.
    • Cheng C.H.
    • et al.

    Colonic transit time in long-term dialysis patients.

    Am J Kidney Dis. 2004; 44: 322-327

  • Dietary iron supplementation: a proinflammatory attack on the intestine?.

    Gut. 2015; 64: 696-697

  • Intestinal-renal syndrome: mirage or reality?.

    Blood Purif. 2011; 31: 70-76

    • Lin C.J.
    • Wu V.
    • Wu P.C.
    • Wu C.J.

    Meta-analysis of the associations of p-cresyl sulfate (PCS) and indoxyl sulfate (IS) with cardiovascular events and all-cause mortality in patients with chronic renal failure.

    PLoS One. 2015; 10: e0132589

    • Meijers B.K.
    • Claes K.
    • Bammens B.
    • et al.

    p-Cresol and cardiovascular risk in mild-to-moderate kidney disease.

    Clin J Am Soc Nephrol. 2010; 5: 1182-1189

    • Wu I.W.
    • Hsu K.H.
    • Hsu H.J.
    • et al.

    Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients-A prospective cohort study.

    Nephrol Dial Transpl. 2012; 27: 1169-1175

  • Probiotics and gastrointestinal health.

    Am J Gastroenterol. 2000; 95: S2-S4

    • Liu Q.
    • Duan Z.P.
    • Ha D.K.
    • et al.

    Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis.

    Hepatology. 2004; 39: 1441-1449

    • Chiva M.
    • Soriano G.
    • Rochat I.
    • et al.

    Effect of Lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis.

    J Hepatol. 2002; 37: 456-462

    • Taki K.
    • Takayama F.
    • Niwa T.

    Beneficial effects of Bifidobacteria in a gastroresistant seamless capsule on hyperhomocysteinemia in hemodialysis patients.

    J Ren Nutr. 2005; 15: 77-80

    • Rossi M.
    • Johnson D.W.
    • Morrison M.
    • et al.

    Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): a randomized trial.

    Clin J Am Soc Nephrol. 2016; 11: 223-231

    • Guida B.
    • Germano R.
    • Trio R.
    • et al.

    Effect of short-term synbiotic treatment on plasma p-cresol levels in patients with chronic renal failure: a randomized clinical trial.

    Nutr Metab Cardiovasc Dis. 2014; 24: 1043-1049

    • Hyun H.S.
    • Paik K.H.
    • Cho H.Y.

    p-Cresyl sulfate and indoxyl sulfate in pediatric patients on chronic dialysis.

    Korean J Pediatr. 2013; 56: 159-164

    • Borges N.A.
    • Carmo F.L.
    • Stockler-Pinto M.B.
    • et al.

    Probiotic supplementation in chronic kidney disease: a double-blind, randomized, placebo-controlled trial.

    J Ren Nutr. 2018; 28: 28-36

    • Rajkumar H.
    • Mahmood N.
    • Kumar M.
    • et al.

    Effect of probiotic (VSL#3) and omega-3 on lipid profile, insulin sensitivity, inflammatory markers, and gut colonization in overweight adults: a randomized, controlled trial.

    Mediators Inflamm. 2014; 2014: 348959

    • Chen H.S.
    • Lee K.C.
    • Cheng C.T.
    • et al.

    Application of bioimpedance spectroscopy in Asian dialysis patients (ABISAD): serial follow-up and dry weight evaluation.

    Clin Kidney J. 2013; 6: 29-34

  • Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group.

    J Am Soc Nephrol. 1996; 7: 198-207

    • Ware J.E.
    • Sherbourne C.D.

    The MOS 36-item short-form health survey (SF-36). I. Conceptual Framework and item Selection.

    Med Care. 1992; 30: 473-483

  • SF-36 physical and mental health summary scales: a manual for users of version 1.

    2nd ed. QualityMetric Incorporated,
    Lincoln, RI2001: 2/3

    • Andersen K.
    • Kesper M.S.
    • Marschner J.A.
    • et al.

    Intestinal dysbiosis, barrier dysfunction, and bacterial translocation account for CKD-related systemic inflammation.

    J Am Soc Nephrol. 2017; 28: 76-83

    • Vitetta L.
    • Linnane A.W.
    • Gobe G.C.

    From the gastrointestinal tract (GIT) to the kidneys: live bacterial cultures (probiotics) mediating reductions of uremic toxin levels via free radical signaling.

    Toxins (Basel). 2013; 5: 2042-2057

    • Wang I.K.
    • Wu Y.Y.
    • Yang Y.F.
    • et al.

    The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients: a randomised, double-blind, placebo-controlled trial.

    Benef Microbes. 2015; 6: 423-430

    • Soleimani A.
    • Zarrati Mojarrad M.
    • Bahmani F.
    • et al.

    Probiotic supplementation in diabetic hemodialysis patients has beneficial metabolic effects.

    Kidney Int. 2017; 91: 435-442

    • Shariaty Z.
    • Mahmoodi Shan G.R.
    • Farajollahi M.
    • et al.

    The effects of probiotic supplement on hemoglobin in chronic renal failure patients under hemodialysis: a randomized clinical trial.

    J Res Med Sci. 2017; 22: 74

    • Pisano A.
    • D’Arrigo G.
    • Coppolino G.
    • et al.

    Biotic supplements for renal patients: a systematic review and meta-analysis.

    Nutrients. 2018; 10: 1224

    • Kazemi A.
    • Soltani S.
    • Ghorabi S.
    • et al.

    Effect of probiotic and synbiotic supplementation on inflammatory markers in health and disease status: a systematic review and meta-analysis of clinical trials.

    Clin Nutr. 2020; 39: 789-819

    • Jia L.
    • Jia Q.
    • Yang J.
    • et al.

    Efficacy of probiotics supplementation on chronic kidney disease: a systematic review and meta-analysis.

    Kidney Blood Press Res. 2018; 43: 1623-1635

    • de Faria Barros A.
    • Borges N.A.
    • Nakao L.S.
    • et al.

    Effects of probiotic supplementation on inflammatory biomarkers and uremic toxins in non-dialysis chronic kidney patients: a double-blind, randomized, placebo-controlled trial.

    J Funct Foods. 2018; 46: 378-383

    • Thongprayoon C.
    • Kaewput W.
    • Hatch S.T.
    • et al.

    Effects of probiotics on inflammation and uremic toxins among patients on dialysis: a systematic review and meta-analysis.

    Dig Dis Sci. 2019; 64: 469-479

    • Natarajan R.
    • Pechenyak B.
    • Vyas U.
    • et al.

    Randomized controlled trial of strain-specific probiotic formulation (Renadyl) in dialysis patients.

    Biomed Res Int. 2014; 2014: 568571

    • Simeoni M.
    • Citraro M.L.
    • Cerantonio A.
    • et al.

    Correction to: an open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD).

    Eur J Nutr. 2019; 58: 2157

    • Sirich T.L.
    • Plummer N.S.
    • Gardner C.D.
    • et al.

    Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients.

    Clin J Am Soc Nephrol. 2014; 9: 1603-1610

    • Poesen R.
    • Evenepoel P.
    • de Loor H.
    • et al.

    The influence of prebiotic arabinoxylan oligosaccharides on microbiota derived uremic retention solutes in patients with chronic kidney disease: a randomized controlled trial.

    PLoS One. 2016; 11: e0153893

    • Esgalhado M.
    • Kemp J.A.
    • Azevedo R.
    • et al.

    Could resistant starch supplementation improve inflammatory and oxidative stress biomarkers and uremic toxins levels in hemodialysis patients? A pilot randomized controlled trial.

    Food Funct. 2018; 9: 6508-6516

    • Eidi F.
    • Poor-Reza Gholi F.
    • Ostadrahimi A.
    • et al.

    Effect of Lactobacillus Rhamnosus on serum uremic toxins (phenol and P-Cresol) in hemodialysis patients: a double blind randomized clinical trial.

    Clin Nutr ESPEN. 2018; 28: 158-164

    • McFarlane C.
    • Ramos C.I.
    • Johnson D.W.
    • et al.

    Prebiotic, probiotic, and synbiotic supplementation in chronic kidney disease: a systematic review and meta-analysis.

    J Ren Nutr. 2019; 29: 209-220

    • Nakabayashi I.
    • Nakamura M.
    • Kawakami K.
    • et al.

    Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study.

    Nephrol Dial Transpl. 2011; 26: 1094-1098

    • Ramos C.I.
    • Armani R.G.
    • Canziani M.E.F.
    • et al.

    Effect of prebiotic (fructooligosaccharide) on uremic toxins of chronic kidney disease patients: a randomized controlled trial.

    Nephrol Dial Transpl. 2019; 34: 1876-1884

    • McFarland L.V.
    • Evans C.T.
    • Goldstein E.J.C.

    Strain-specificity and disease-specificity of probiotic efficacy: a systematic review and meta-analysis.

    Front Med (Lausanne). 2018; 5: 124

    • Jeng Y.
    • Lim P.S.
    • Wu M.Y.
    • et al.

    Proportions of proinflammatory monocytes are important predictors of mortality risk in hemodialysis patients.

    Mediators Inflamm. 2017; 2017: 1070959

    • Dai L.
    • Golembiewska E.
    • Lindholm B.
    • et al.

    End-stage renal disease, inflammation and cardiovascular outcomes.

    Contrib Nephrol. 2017; 191: 32-43

    • Lepper P.M.
    • Schumann C.
    • Triantafilou K.
    • et al.

    Association of lipopolysaccharide-binding protein and coronary artery disease in men.

    J Am Coll Cardiol. 2007; 50: 25-31

    • Wang F.
    • Jiang H.
    • Shi K.
    • et al.

    Gut bacterial translocation is associated with microinflammation in end-stage renal disease patients.

    Nephrology (Carlton). 2012; 17: 733-738

    • Awoyemi A.
    • Troseid M.
    • Arnesen H.
    • et al.

    Markers of metabolic endotoxemia as related to metabolic syndrome in an elderly male population at high cardiovascular risk: a cross-sectional study.

    Diabetol Metab Syndr. 2018; 10: 59

    • Lim P.S.
    • Chang Y.K.
    • Wu T.K.

    Serum lipopolysaccharide-binding protein is associated with chronic inflammation and metabolic syndrome in hemodialysis patients.

    Blood Purif. 2019; 47: 28-36

    • Vaziri N.D.
    • Liu S.
    • Lau W.L.
    • et al.

    High amylose resistant starch diet ameliorates oxidative stress, inflammation, and progression of chronic kidney disease.

    PLoS One. 2014; 9: e114881

    • Kieffer D.A.
    • Piccolo B.D.
    • Vaziri N.D.
    • et al.

    Resistant starch alters the gut microbiota, uremic retention solutes and xeno-metabolite profiles concurrent with amelioration of chronic kidney disease in rats.

    Am J Physiol Ren Physiol. 2016; 310: F857-F871

    • Tayebi Khosroshahi H.
    • Abedi B.
    • Habibi B.
    • et al.

    The salutary effect of amylose resistant starch (HAM-RS2) supplementation on biomarkers of inflammation and oxidative stress in hemodialysis patients.

    Hemodialysis Int. 2018; 22: 492-500

    • Laffin M.R.
    • Tayebi Khosroshahi H.
    • Park H.
    • et al.

    Amylose resistant starch (HAM-RS2) supplementation increases the proportion of Faecalibacterium bacteria in end-stage renal disease patients: microbial analysis from a randomized placebo-controlled trial.

    Hemodial Int. 2019; 23: 343-347

  • Source Link

    Related Posts

    Leave a Comment

    This website uses cookies to improve your experience. We will assume you are ok with this, but you can opt-out if you wish. Accept Read More

    %d bloggers like this: